Okudaira K, Yabana T, Takahashi H, Iizuka H, Nakajima K, Saito A
Kanagawa Prefectural Center of Psychiatry, Serigaya Hospital, Japan.
Seishin Shinkeigaku Zasshi. 1996;98(4):203-12.
There are different opinions about the cause of chronic psychiatric symptoms observed in drug abusers between Japanese and foreign psychiatrists. The Japanese seem to recognize the chronic psychosis as the result of drug abuse. In the other hand, foreigners diagnose these cases as dual diagnosis of drug abuse and psychosis. Authors studied the problem in this research. One of the authors has examined 120 inhalant abusers of all, in- and out-patients in Kanagawa Prefectural Center of Psychiatry, Serigaya Hospital from 1991 to 1995. These patients were classified into three groups: psychosis group (23 patients), dependence group (51 patients) and abuse group (46 patients) according to their clinical courses and psychiatric symptoms. The psychosis group consists of patients who showed psychiatric symptoms such as hallucination, delusion and thought disturbance for long time after detoxification. The dependence group contains patients whose inhalant dependence was severe and met DSM-4 Diagnostic Criteria for Substance Dependence, but manifested no chronic psychiatric symptoms after detoxification. The patients belonging to abuse group were at the earlier stages of inhalant abuse and had no chronic psychiatric symptoms. The average age of the first inhalant abuse was 14.7 years old in the psychosis group, 14.8 years in the dependence group and 14.7 years in the abuse group. The average years of abuse was 9.0 years in the psychosis group, and 8.5 years in the dependence group. There was little difference between these two groups. The psychosis patients manifested chronic symptoms 5.7 years on average after the first abuse of inhalants. About one forth (26.1%) of the psychosis patients and only 5.9% of the dependence patients had family history of schizophrenia. The difference was statistically significant. These results suggest that chronic psychiatric symptoms are caused not only by inhalant abuse, but also by the genetic factors of psychosis of each patient. There have been several reports that many patients with dual diagnosis of substance dependence and other mental disorders are poly-drug abusers. In our study, 43.4% of the psychosis group patients and 19.6% of the dependence group patients had the past history of abuse of other drugs including methamphetamine and marijuana. The difference was, however, not statistically significant.
日本和外国的精神科医生对于吸毒者中出现的慢性精神症状的成因存在不同观点。日本人似乎将慢性精神病视为药物滥用的结果。另一方面,外国人则将这些病例诊断为药物滥用和精神病的双重诊断。作者在本研究中探讨了这个问题。其中一位作者在1991年至1995年期间,对神奈川县立精神中心相模原医院的120名吸入剂滥用者进行了研究,这些患者包括门诊和住院患者。根据他们的临床病程和精神症状,这些患者被分为三组:精神病组(23名患者)、依赖组(51名患者)和滥用组(46名患者)。精神病组由那些在戒毒后长时间出现幻觉、妄想和思维紊乱等精神症状的患者组成。依赖组包含那些吸入剂依赖严重且符合《精神疾病诊断与统计手册》第四版物质依赖诊断标准,但在戒毒后未表现出慢性精神症状的患者。属于滥用组的患者处于吸入剂滥用的早期阶段,没有慢性精神症状。精神病组首次吸入剂滥用的平均年龄为14.7岁,依赖组为14.8岁,滥用组为14.7岁。这两组之间差异不大。精神病患者在首次滥用吸入剂后平均5.7年出现慢性症状。约四分之一(26.1%)的精神病患者和仅5.9%的依赖患者有精神分裂症家族史。差异具有统计学意义。这些结果表明,慢性精神症状不仅由吸入剂滥用引起,还由每个患者精神病的遗传因素导致。有几份报告称,许多患有物质依赖和其他精神障碍双重诊断的患者是多药滥用者。在我们的研究中,43.4%的精神病组患者和19.6%的依赖组患者有包括甲基苯丙胺和大麻在内的其他药物滥用史。然而,差异没有统计学意义。